Preclinical studies have shown that CYP2E1 expression is upregulated by chronic alcohol intake and by high fat intake [58,59,60], while biopsy studies have revealed upregulated CYP2E1 expression in livers of NAFLD patients, compared to those of healthy subjects [61]. This evidence concerns the gene CYP2E1 and metabolic dysfunction-associated steatotic liver disease.